| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |